Inventor · disambiguated record
Joseph M. Fortunak
Also filed as: FORTUNAK JOSEPH · FORTUNAK JOSEPH M · FORTUNAK JOSEPH MARIAN
19 granted patents·5 pending applications·169 citations·filing 1988–2024
94Inventor score
Files withDU PONT PHARM CO8SMITHKLINE BEECHAM CORP6PHILERA NEW ZEALAND LTD4BRISTOL MYERS SQUIBB PHARMA CO2BRISTOL MYERS SQUIBB PHARMA1
Top patents by PatentIndex Score
24 records- 0188US5468859AProcess for asymmetric total synthesis of camptothecin analoguesSMITHKLINE BEECHAM CORP·Filed 1994·Granted Nov 21, 1995·30 cites·8 claims
- 0285US5700939AIntermediates useful in camptothecin synthesisSMITHKLINE BEECHAM CORP·Filed 1996·Granted Dec 23, 1997·25 cites·10 claims
- 0377US5734056AProcess for the preparation of certain 9-substituted camptothecinsSMITHKLINE BEECHAM CORP·Filed 1995·Granted Mar 31, 1998·60 cites·42 claims
- 0476US4997954AProcess for preparing substituted isoindolinone derivativesSMITH KLINE FRENCH LAB·Filed 1988·Granted Mar 5, 1991·12 cites·8 claims
- 0572US2025114312A1Treatment of copper disordersPHILERA NEW ZEALAND LTD·Filed 2024·Application pending·0 cites
- 0670US5155225AMethod for making certain pyrano[3',4':6,7]indolizino-[1,2-B]quinolinonesSMITHKLINE BEECHAM CORP·Filed 1990·Granted Oct 13, 1992·12 cites·5 claims
- 0767US6297410B1Process for the preparation of cyclopropylacetyleneDU PONT PHARM CO·Filed 2000·Granted Oct 2, 2001·3 cites·1 claims
- 0867US2024043370A1Method for triethylenetetramine purificationPHILERA NEW ZEALAND LTD·Filed 2023·Application pending·0 cites
- 0963US6140499A4,4-disubstituted-1,4-dihydro-2H-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 1998·Granted Oct 31, 2000·7 cites·7 claims
- 1063US5405963AProcess for asymmetric total synthesis of camptothecin analoguesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Apr 11, 1995·6 cites·14 claims
- 1163US2022280451A1Treatment of copper disorderPHILERA NEW ZEALAND LTD·Filed 2022·Application pending·0 cites
- 1261US6492515B24,4-disubstituted-1, 4-dihydro-2H-3, 1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Dec 10, 2002·1 cites·4 claims
- 1358US6049019AProcess for the preparation of cyclopropylacetyleneDU PONT PHARM CO·Filed 1998·Granted Apr 11, 2000·5 cites·13 claims
- 1457US6452000B2Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediateBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted Sep 17, 2002·1 cites·21 claims
- 1555US2022280450A1Prevention and treatment of coronavirus and related respiratory infectionsPHILERA NEW ZEALAND LTD·Filed 2022·Application pending·0 cites
- 1647US6303780B14,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as HIV reverse transcriptase inhibitors and intermediates and processes for making the sameDU PONT PHARM CO·Filed 2000·Granted Oct 16, 2001·0 cites·9 claims
- 1745US6194569B1Efficient process for the preparation of [S-(R,S)]-N-[1,3-benzodioxol-5-yl)butyl]-3,3-diethyl-2[4-[4-methyl-1-piperazinyl)carbonyl]phenoxy]-4-oxo-1-azetidine carboxamide, a human leukocyte elastase inhibitorDU PONT PHARM CO·Filed 1999·Granted Feb 27, 2001·3 cites·12 claims
- 1844US5541329AIntermediates prepared in an asymmetric total synthesis of camptothecin analogsSMITHKLINE BEECHAM CORP·Filed 1994·Granted Jul 30, 1996·1 cites·8 claims
- 1941US6555686B2Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitorsBRISTOL MYERS SQUIBB PHARMA·Filed 2001·Granted Apr 29, 2003·0 cites·44 claims
- 2041US6288297B1Process for the preparation of cyclopropylacetyleneDU PONT PHARM CO·Filed 1999·Granted Sep 11, 2001·2 cites·19 claims
- 2137US6359164B1Process for the preparation of cyclopropylacetyleneFiled 1999·Granted Mar 19, 2002·1 cites·22 claims
- 2233US2001044540A1Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitorsFiled 2001·Application pending·0 cites
- 2330US6214847B1Crystalline 10,10-Bis((2-fluoro-4-pyridinyl)methyl)-9(10H)-Anthracenone and an improved process for preparing the sameDU PONT PHARM CO·Filed 1998·Granted Apr 10, 2001·0 cites·8 claims
- 2428US6218534B1Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediateDU PONT PHARM CO·Filed 1998·Granted Apr 17, 2001·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Joseph M. Fortunak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →